Meet Salvatore Mercuri, Ph.D.

Head of Research and Development

Monteggio, Switzerland

Salvatore Mercuri serves as head of Research and Development at Lonza’s site in Monteggio, Switzerland, which is Lonza’s European Center for Excellence for Particle Engineering, specializing in particle size control through micronization. Salvatore’s expertise includes the development of highly potent active pharmaceutical ingredients (HPAPIs) and the formulation of modified-release solid oral dosage forms.

Our locations

Our Micronization Center of Excellence

Monteggio, Switzerland

Our Monteggio site serves as the European Center of Excellence for particle engineering and provides particle size control expertise through micronization technologies. The Monteggio site is an integral component of our drug product design, development and manufacturing services network.

With 19 production suites and 37 cGMP jet and pin mills, the site is well equipped to support your compound at any point of the product lifecycle. We provide micronization services from a few grams to tons of APIs. Dedicated areas for steroids, cryogenic capabilities for elastic and semi-solid milling, and isolation for highly potent active pharmaceutical ingredients (HPAPIs) are available. Our skilled team of engineers and technical staff evaluate your compound carefully and adapt equipment and processing parameters to address dissolution rate, stability, flowability and other performance issues required to meet target product profiles for oral solid, inhaled and other drug delivery routes.

Learn more